Abstract
The delivery of chemotherapy through the implantable hepatic infusion pump in the management of patients with hepatic metastases secondary to carcinoma of the colon and rectum is evaluated in this preliminary prospective study. Patients were selected according to hepatic lobar distribution and magnitude, age, and general systemic evaluation. Infusion pumps were implanted in a total of 14 patients who were judged to be unsuitable for hepatic resection. After pump implantation all patients were alive and well and receiving regional perfusion chemotherapy. For the nine patients in this study who have been monitored for a full six months, the median decrease in CEA levels was 49 percent. On computerized axial tomography (CT) and/or liver-spleen scan, five patients showed greater than 50 percent reduction in tumor size. All patients have demonstrated minimal systemic toxicity and have maintained a good quality of life. The results encourage further evaluation of perfusion chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sullivan RD, Miller E, Sikes MP. Antimetabolite-metabolite combination cancer chemotherapy: effects of intra-arterial methotrexate-intramuscular citrovorum factor therapy in human cancer. Cancer 1959;12:1248–62.
Watkins E Jr, Sullivan RD. Cancer chemotherapy by prolonged arterial infusion. Surg Gynecol Obstet 1964;118:3–19.
Sullivan RD, Norcross JW, Watkins E Jr. Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 1964;270:321–7.
Reed ML, Vaitkevicius VK, Al-Sarrof M, et al. The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies. Cancer 1981;47:402–9.
Sullivan RD, Zurek WZ. Chemotherapy for liver cancer by protracted ambulatory infusion. JAMA 1965;194:481–6.
Cady B, Oberfield RA. Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg 1974;127:220–7.
Sundqvist K, Hafstrom LO, Jonsson PE, et al. Treatment of liver cancer with regional intraarterial 5-FU infusion. Am J Surg 1978;136:328–31.
Blackshear PJ, Dorman FD, Blackshear PL Jr, et al. The design and initial testing of an implantable infusion pump. Surg Gynecol Obstet 1972;134:51–6.
Blackshear PJ. Implantable drug-delivery systems. Sci Am 1979;241:66–73.
Buchwald H, Grage TB, Vassilopoulos PP, et al. Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 1980;45:866–9.
Balch CM, Urist MM, Soong SJ, McGregor M. A prospective Phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 1983;198:567–73.
Ensminger W, Niederhuber J, Dakhil S, Thrall J, Wheeler R. Totally implanted drug delivery system for hepatic arterial chemotherapy. Cancer Treat Rep 1981;65:393–400.
Cohen AM, Greenfield A, Wood WC, et al. Treatment of hepatic metastases by transaxillary hepatic artery chemotherapy using an implanted drug pump. Cancer 1983;51:2013–9.
Author information
Authors and Affiliations
Additional information
Supported in part by the Dorothy Rider Pool Health Care Trust Fund.
About this article
Cite this article
Riether, R.D., Khubchandani, I.T., Sheets, J.A. et al. A prospective study of continuous hepatic perfusion with implantable pump. Dis Colon Rectum 28, 24–26 (1985). https://doi.org/10.1007/BF02553901
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02553901